Paper34099682
Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance.
Wang H and 9 others. Nat Commun, 2021. Cited by 143 papers, by iCite.
Cite this record
ConductScience Library. Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance. Papers, record 34099682. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/34099682
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance.
- PubMed
Topics12
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Anti-Bacterial Agents | Major topic |
| Drug Resistance, Bacterial | Major topic |
| Metal Nanoparticles | Major topic |
| Silver | Major topic |
| Staphylococcus aureus | Major topic |
| Crystallography, X-Ray | |
| Methicillin-Resistant Staphylococcus aureus | |
| Microbial Sensitivity Tests | |
| Phosphogluconate Dehydrogenase | |
| Proteomics | |
| Silver Nitrate | |
| Staphylococcal Infections |
Source PubMed
Comments and corrections1
PubMed's comments and corrections, NLM's own indexing: retractions first, then expressions of concern, errata and updates, and comments last.
| Kind | PMID | Title | In Papers |
|---|---|---|---|
| Erratum in | 34210983 | Author Correction: Multi-target mode of action of silver against Staphylococcus aureus endows it with capability to combat antibiotic resistance. | https://conductscience.org/library/papers/34210983 |
Source PubMed
References66
The papers the reference list in PubMed's record names, those in our copy of PubMed, in the list's order.
| Order | PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|---|
| 1 | 19680247 | Waves of resistance: Staphylococcus aureus in the antibiotic era. | Nat Rev Microbiol | 2009 | https://conductscience.org/library/papers/19680247 | PubMed |
| 2 | 9709046 | Staphylococcus aureus infections. | N Engl J Med | 1998 | https://conductscience.org/library/papers/9709046 | PubMed |
| 3 | 18462090 | Pathogenesis of methicillin-resistant Staphylococcus aureus infection. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18462090 | PubMed |
| 4 | 18462091 | Increasing antibiotic resistance among methicillin-resistant Staphylococcus aureus strains. | Clin Infect Dis | 2008 | https://conductscience.org/library/papers/18462091 | PubMed |
| 5 | 11871491 | Vancomycin-resistant Staphylococcus aureus: a new model of antibiotic resistance. | Lancet Infect Dis | 2001 | https://conductscience.org/library/papers/11871491 | PubMed |
| 6 | 32488173 | Antimicrobial use, drug-resistant infections and COVID-19. | Nat Rev Microbiol | 2020 | https://conductscience.org/library/papers/32488173 | PubMed |
| 7 | 23669886 | Antimicrobial activity of metals: mechanisms, molecular targets and applications. | Nat Rev Microbiol | 2013 | https://conductscience.org/library/papers/23669886 | PubMed |
| 8 | 24456146 | Metallodrugs in medicinal inorganic chemistry. | Chem Rev | 2014 | https://conductscience.org/library/papers/24456146 | PubMed |
| 9 | 22322154 | Recent advances in bioinorganic chemistry of bismuth. | Curr Opin Chem Biol | 2012 | https://conductscience.org/library/papers/22322154 | PubMed |
| 10 | 28745454 | Metal-based antimicrobial strategies. | Microb Biotechnol | 2017 | https://conductscience.org/library/papers/28745454 | PubMed |
| 11 | 30596427 | Systems Approaches for Unveiling the Mechanism of Action of Bismuth Drugs: New Medicinal Applications beyond Helicobacter Pylori Infection. | Acc Chem Res | 2019 | https://conductscience.org/library/papers/30596427 | PubMed |
| 12 | 32206266 | Metal complexes as a promising source for new antibiotics. | Chem Sci | 2020 | https://conductscience.org/library/papers/32206266 | PubMed |
| 13 | 30257953 | Gallium disrupts bacterial iron metabolism and has therapeutic effects in mice and humans with lung infections. | Sci Transl Med | 2018 | https://conductscience.org/library/papers/30257953 | PubMed |
| 14 | 25831516 | Auranofin exerts broad-spectrum bactericidal activities by targeting thiol-redox homeostasis. | Proc Natl Acad Sci U S A | 2015 | https://conductscience.org/library/papers/25831516 | PubMed |
| 15 | 31360415 | Combination of gallium(iii) with acetate for combating antibiotic resistant Pseudomonas aeruginosa. | Chem Sci | 2019 | https://conductscience.org/library/papers/31360415 | PubMed |
| 16 | 29382822 | Bismuth antimicrobial drugs serve as broad-spectrum metallo-β-lactamase inhibitors. | Nat Commun | 2018 | https://conductscience.org/library/papers/29382822 | PubMed |
| 17 | 21258393 | Give silver a shine. | Nat Chem | 2011 | https://conductscience.org/library/papers/21258393 | PubMed |
| 18 | 23488929 | Nanobio silver: its interactions with peptides and bacteria, and its uses in medicine. | Chem Rev | 2013 | https://conductscience.org/library/papers/23488929 | PubMed |
| 19 | 22928774 | Silver as an antimicrobial: facts and gaps in knowledge. | Crit Rev Microbiol | 2013 | https://conductscience.org/library/papers/22928774 | PubMed |
| 20 | 26432451 | Proteomic Analysis to Elucidate the Antibacterial Action of Silver Ions Against Bovine Mastitis Pathogens. | Biol Trace Elem Res | 2016 | https://conductscience.org/library/papers/26432451 | PubMed |
Cited by69
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 143 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42653794 | Antibiofilm Substantivity of AgNPs in Clinical Oral Biofilms from Patients with Motor and Intellectual Disabilities: An In Vitro and Exploratory Study. | Pharmaceuticals (Basel) | 2026 | https://conductscience.org/library/papers/42653794 | PubMed |
| 42543002 | Broad-Spectrum Antibacterial Electrospun PCL-Silver Fibers Coupled with Chromogenic Hydrogel for Infection Sensing. | Curr Microbiol | 2026 | https://conductscience.org/library/papers/42543002 | PubMed |
| 42482505 | Engineering "Yin-Yang" Ag/AgCl-Polymer Nanotherapeutic for Tunable Silver Ion Release With Improved In Vivo Biocompatibility and Antimicrobial Potency. | Small | 2026 | https://conductscience.org/library/papers/42482505 | PubMed |
| 42272489 | Graphene oxide-supported berberine and aloe-emodin nanocomposites for dual-drug release and antimicrobial therapy. | Fundam Res | 2026 | https://conductscience.org/library/papers/42272489 | PubMed |
| 42211032 | Safety-constrained evaluation of antibacterial multicomponent borate glasses. | Biomater Biosyst | 2026 | https://conductscience.org/library/papers/42211032 | PubMed |
| 42135462 | Repurposing Azeliragon as a novel antibacterial agent against methicillin-resistant Staphylococcus aureus via combined membrane phospholipids and cell wall targeting. | Commun Biol | 2026 | https://conductscience.org/library/papers/42135462 | PubMed |
| 42026203 | The arsenic proteome in cancer: Unravelling molecular mechanisms of anticancer drugs. | J Biol Inorg Chem | 2026 | https://conductscience.org/library/papers/42026203 | PubMed |
| 41961440 | Multifunctional platinum nanoparticles from Chlorella vulgaris: a statistical optimization study. | AMB Express | 2026 | https://conductscience.org/library/papers/41961440 | PubMed |
| 41759530 | Phylogenomics-driven metalloantibiotic engineering: Overcoming ciprofloxacin resistance in Pseudomonasaeruginosa with sideromycin-bismuth synergy. | Cell Rep Med | 2026 | https://conductscience.org/library/papers/41759530 | PubMed |
| 41586309 | Sustainable, scalable nanotechnology approach using filtrate from Raphanus sativus in combating multidrug-resistant pathogens and causing neglected tropical diseases. | Front Cell Infect Microbiol | 2025 | https://conductscience.org/library/papers/41586309 | PubMed |
| 41156852 | Combating Foodborne MRSA: Identification and Silver Nanoparticle-Based Antibacterial Strategies with Antibiotic Synergy and Resistance Evolution Assessment. | Microorganisms | 2025 | https://conductscience.org/library/papers/41156852 | PubMed |
| 41104151 | Unprecedented allosteric inhibition of E. coli malate dehydrogenase by silver(i) from atomic resolution analysis. | Chem Sci | 2025 | https://conductscience.org/library/papers/41104151 | PubMed |
| 40871505 | Synergistic Antibacterial Effect of Eugenol and Biogenic Silver Nanoparticles on Staphylococcus pseudintermedius Isolated from Canine Keratoconjunctivitis Sicca. | Molecules | 2025 | https://conductscience.org/library/papers/40871505 | PubMed |
| 40626069 | Mechanistic insights and therapeutic innovations in engineered nanomaterial-driven disruption of biofilm dynamics. | RSC Adv | 2025 | https://conductscience.org/library/papers/40626069 | PubMed |
| 40488103 | Evaluation of the Antimicrobial and Organic Dye Removal Properties of Silver-Incorporated ZIF‑L Metal-Organic Framework Nanoparticles. | ACS Omega | 2025 | https://conductscience.org/library/papers/40488103 | PubMed |
| 40444966 | A novel silver-ruthenium-based antimicrobial kills Gram-negative bacteria through oxidative stress-induced macromolecular damage. | mSphere | 2025 | https://conductscience.org/library/papers/40444966 | PubMed |
| 40427624 | Silver Nanoparticles (AgNPs) from Lysinibacillus sp. Culture Broths: Antibacterial Activity, Mechanism Insights, and Synergy with Classical Antibiotics. | Biomolecules | 2025 | https://conductscience.org/library/papers/40427624 | PubMed |
| 40284526 | Salicylic Acid-Mediated Silver Nanoparticle Green Synthesis: Characterization, Enhanced Antimicrobial, and Antibiofilm Efficacy. | Pharmaceutics | 2025 | https://conductscience.org/library/papers/40284526 | PubMed |
| 40271847 | Controllable Fabrication of ZnO Nanorod Arrays on the Surface of Titanium Material and Their Antibacterial and Anti-Adhesion Properties. | Materials (Basel) | 2025 | https://conductscience.org/library/papers/40271847 | PubMed |
| 40063057 | Metal-Based Approaches for the Fight against Antimicrobial Resistance: Mechanisms, Opportunities, and Challenges. | J Am Chem Soc | 2025 | https://conductscience.org/library/papers/40063057 | PubMed |
Genes1
The genes the Gene search release ties to the paper: Swiss-Prot's references first, then PubTator's text mining.
| Gene | NCBI Gene ID | Linked by | In Genes |
|---|---|---|---|
| PGD | 5226 | PubTator's text mining | https://conductscience.org/library/genes/5226 |
Source NCBI Gene
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/34099682
GET https://conductscience.org/api/papers/v1/34099682/references?page=2